In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance

Affiliations

• ¹ College of Pharmacy, The University of Michigan, 428 Church Street, Ann Arbor, Michigan, 48109, USA. ytsume@umich.edu.
• ² Merck & Co., Inc., 126 E Lincoln Ave, Rahway, New Jersey, 07065, USA. ytsume@umich.edu.
• ³ Merck & Co., Inc., 126 E Lincoln Ave, Rahway, New Jersey, 07065, USA.
• ⁴ Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
• ⁵ Department of Pharmacy, Uppsala University, Uppsala, Sweden.
• ⁶ College of Pharmacy, The University of Michigan, 428 Church Street, Ann Arbor, Michigan, 48109, USA.
• ⁷ Aerospace Engineering Sciences, University of Colorado, Boulder, Colorado, USA.
• ⁸ Research and Development, Lonza, Bend, Oregon, USA.
• ⁹ Universidad Miguel Hernández de Elche, Elche, Spain.
• ¹⁰ Abbvie, Inc., Chicago, Illinois, USA.
• ¹¹ Merck & Co., Inc., West Point, Pennsylvania, 19486, USA.
• ¹² Eli Lilly and Company, Indianapolis, Indiana, 46285, USA.
• ¹³ Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
• ¹⁴ F. Hoffmann-La Roche, Ltd., Roche Innovation Center, Basel, Switzerland.
• ¹⁵ Food and Drug Administration, Silver Spring, Maryland, 21201, USA.
• ¹⁶ Astellas Pharma Inc., Shizuoka, Japan.
• ¹⁷ Bristol-Myers Squibb Company, New Brunswick, New Jersey, 08903, USA.